What does CUSIP 452907AK4 represent in this 13F holders report?

CUSIP 452907AK4 is the security identifier for 452907AK4 - IMMUNOMEDICS INC - NOTE 4.750% 2/1 used to aggregate holder disclosures.

How many institutions held 452907AK4 - IMMUNOMEDICS INC - NOTE 4.750% 2/1 in Q1 2020?

No institutional holders were reported for 452907AK4 - IMMUNOMEDICS INC - NOTE 4.750% 2/1 in Q1 2020; review adjacent reporting periods for trend context.

IMMUNOMEDICS INC - NOTE 4.750% 2/1

CUSIP: 452907AK4

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class: Debt / NOTE 4.750% 2/1
Total 13F principal: $0
Principal change: -$7,114,705
Total reported market value: $0
Number of holders: 0
Value change: -$29,577,843
Number of sells: 4

Quarterly Holders Quick Answers

What is CUSIP 452907AK4?
CUSIP 452907AK4 identifies 452907AK4 - IMMUNOMEDICS INC - NOTE 4.750% 2/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q4 2019

Recent filing periods for CUSIP 452907AK4:

Q1 2020 Q4 2019 Q3 2019 Q2 2019 Q1 2019 Q4 2018 Q3 2018 Q2 2018

IMMUNOMEDICS INC - NOTE 4.750% 2/1

Q1 2020 13F Holders as of 31 Mar 2020

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of IMMUNOMEDICS INC - NOTE 4.750% 2/1 as of Q1 2020.